%0 Journal Article
%T Short-Term Psychodynamic Psychotherapy in Patients with ¡°Male Depression¡± Syndrome, Hopelessness, and Suicide Risk: A Pilot Study
%A Gloria Angeletti
%A Maurizio Pompili
%A Marco Innamorati
%A Chiara Santucci
%A Valeria Savoja
%A Mark Goldblatt
%A Paolo Girardi
%J Depression Research and Treatment
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/408983
%X Objectives and Methods. This was an observational study of the efficacy of short-term psychodynamic psychotherapy (STPP) in a sample of 35 (30 women and 5 men) patients with moderate-to-severe ¡°male depression¡± (Gotland Scale for Male Depression (GSMD)£¿¡Ý£¿13) comorbid with unipolar mood disorder (dysthymia and major depression) or anxiety disorder. Outcome measures were GSMD and BHS (Beck Hopelessness Scale) score changes from baseline. Results. Patients had a strong response to STPP on the GSMD (estimated mean score change ; partial eta squared£¿£¿ ), but not on the BHS (estimated mean score change ; partial eta squared £¿ ). BHS score changes were significantly associated with GSMD score changes (Pearson's ; ), even when controlling for the severity of hopelessness at the baseline (partial ; ). Conclusions. STPP proved to be effective in patients suffering from ¡°male depression¡± although hopelessness was only marginally reduced by this treatment which points to the need to better understand how STPP can be involved in the reduction of suicide risk. 1. Introduction The term ¡°depression¡± encompasses a wide range of conditions that may occur along a continuum, ranging from milder forms of discomfort to more severe and persistent form, as in the case of major depression. Depression is the leading cause of disability and the 4th leading contributor to the global burden of disease [1, 2] and by the year 2020, it is projected to become the 2nd leading contributor to the global burden of disease in all ages and both sexes [1]. Major depression is the most frequent mental illness in the world [3¨C6]. For example, in the US, the Epidemiological Catchment Area (ECA) Study indicated a one-month prevalence between 1.7% and 3.4% [7], and more recently, the National Comorbidity Survey Replication (NCS-R) estimated a 12-month prevalence of 6.6% [8]. Nevertheless, prevalence of moderate- to- severe depressive symptoms could be much higher [9¨C11]. In 2010, the British National Institute for Health and Clinical Excellence (NICE) commissioned the development of an updated version of the guideline on the treatment and management of depression in adults [12]. The NICE guideline pointed out that people who suffer from depression usually prefer psychological treatments to medication [13] and value outcomes beyond symptom reduction [14]. The NICE guideline indicated that it was not possible to demonstrate a consistent picture of any clinically important benefit for short-term psychodynamic psychotherapy (STPP) in depression. While cognitive-behavioral therapy and interpersonal
%U http://www.hindawi.com/journals/drt/2013/408983/